drugset / Trial / NCT00147758

WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes

NCT00147758

Phase 3 Completed 400 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.

Timeline

Start
2004-06
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Colesevelam Other / unclassified 3.75 g